Poming Kang
Papers
2
Total Citations
49
H-Index
2
About
Dr. Poming Kang is a leading researcher in thoracic surgical oncology, with a focused expertise in the comparative effectiveness and cost-efficiency of minimally invasive lung cancer treatments. His work centers on evaluating robotic-assisted thoracoscopic surgery (RATS) against traditional open thoracotomy and video-assisted thoracoscopic surgery (VATS) for operable non-small cell lung cancer. Dr. Kang’s landmark 2021 study, cited 34 times, provides critical cost-effectiveness data that helps surgeons and policymakers weigh the high upfront costs of robotic platforms against potential benefits like reduced hospital stays and complications. He further advanced the field by identifying key risk factors for conversion from robotic or video-assisted procedures to open surgery, a 2021 paper with 15 citations that guides preoperative patient selection and surgical planning. By bridging economic analysis with clinical outcomes, Dr. Kang’s research empowers evidence-based decision-making in thoracic surgery, directly impacting patient care and resource allocation. His work is essential reading for clinicians and health economists seeking to optimize surgical strategies for lung cancer in an era of rapidly evolving technology.
Research Focus
Key Achievements
Top Papers
- 1
- 2